The vascular microenvironment and systemic sclerosis

International Journal of Rheumatology

Volumn 2010, Issue , 2010, Pages

  Frech, Tracy ^a   Hatton, Nathan ^a   Markewitz, Boaz ^a   Scholand, Mary Beth ^a   Cawthon, Richard ^a   Patel, Amit ^a   Sawitzke, Allen ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHEMOKINE RECEPTOR CXCR4; DASATINIB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; NILOTINIB; PLATELET DERIVED GROWTH FACTOR; SMAD PROTEIN; STROMAL CELL DERIVED FACTOR 1; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CELL ACTIVITY; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; ENDOTHELIAL PROGENITOR CELL; HUMAN; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MICROVASCULARIZATION; MICROVASCULATURE; MONOCYTE; ORGAN INJURY; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS; TELOMERE;

EID: 79955098372     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2010/362868     Document Type: Review

References (57)

1. Mller-Ladner U., Distler O., Ibba-Manneschi L., Neumann E., Gay S., Mechanisms of vascular damage in systemic sclerosis Autoimmunity 2009 42 7 587 595
2. Distler J. H. W., Gay S., Distler O., Angiogenesis and vasculogenesis in systemic sclerosis Rheumatology 2006 45 3 iii26 iii27
3. Feghali-Bostwick C., Medsger T. A. Jr., Wright T. M., Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies Arthritis Rheumatism 2003 48 7 1956 1963 (Pubitemid 36828691)
4. Arnett F. C., Cho M., Chatterjee S., Aguilar M. B., Reveille J. D., Mayes M. D., Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts Arthritis Rheumatism 2001 44 6 1359 1362 (Pubitemid 32537534)
5. Gorlova O., Weng S. F., Ying J., Wigley F., Hummers L., Genome-wide association study of systemic sclerosis in a large US cohort of over 1,500 cases. Abstract 548, Arthritis Rheumatism, vol. 60, 2009
6. Allanore Y., Dieude P., Boileau C., Genetic background of systemic sclerosis: autoimmune genes take centre stage Rheumatology (Oxford) 2010 49 2 203 210
7. Arnett F. C., Gourh P., Shete S., Ahn C. W., Honey R. E., Agarwal S. K., Tan F. K., McNearney T., Fischbach M., Fritzler M. J., Mayes M. D., Reveille J. D., Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls Annals of the Rheumatic Diseases 2010 69 5 822 827
8. Frech T., Khanna D., Markewitz B., Mineau G., Pimentel R., Sawitzke A., Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study Arthritis Rheumatism 2010 62 7 2109 2116
9. Avouac J., Juin F., Wipff J., Couraud P. O., Chiocchia G., Kahan A., Boileau C., Uzan G., Allanore Y., Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity Annals of the Rheumatic Diseases 2008 67 10 1455 1460
10. Freemont A. J., Hoyland J., Fielding P., Hodson N., Jayson M. I. V., Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy British Journal of Dermatology 1992 126 6 561 568
11. Prescott R. J., Freemont A. J., Jones C. J. P., Hoyland J., Fielding P., Sequential dermal microvascular and perivascular changes in the development of scleroderma Journal of Pathology 1992 166 3 255 263
12. Zhu S., Evans S., Yan B., Povsic T. J., Tapson V., Goldschmidt-Clermont P. J., Dong C., Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells Circulation 2008 118 21 2156 2165
13. Kahaleh M. B., Vascular involvement in systemic sclerosis (SSc) Clinical and Experimental Rheumatology 2004 22 3 S19 S23
14. Distler J. H. W., Allanore Y., Avouac J., Giacomelli R., Guiducci S., Moritz F., Akhmetshina A., Walker U. A., Gabrielli A., Mller-Ladner U., Tyndall A., Matucci-Cerinic M., Distler O., EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells Annals of the Rheumatic Diseases 2009 68 2 163 168
15. Minamino T., Miyauchi H., Yoshida T., Tateno K., Kunieda T., Komuro I., Vascular cell senescence and vascular aging Journal of Molecular and Cellular Cardiology 2004 36 2 175 183 (Pubitemid 38202345)
16. Tarhan F., Vural F., Kosova B., Aksu K., Cogulu O., Keser G., Gndz C., Tombuloglu M., Oder G., Karaca E., Doganavsargil E., Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis Rheumatology International 2008 28 6 579 583 (Pubitemid 351422615)
17. Ohtsuka T., Yamakage A., Yamazaki S., The polymorphism of telomerase RNA component gene in patients with systemic sclerosis British Journal of Dermatology 2002 147 2 250 254
18. MacIntyre A., Brouilette S. W., Lamb K., Radhakrishnan K., McGlynn L., Chee M. M., Parkinson E. K., Freeman D., Madhok R., Shiels P. G., Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion Annals of the Rheumatic Diseases 2008 67 12 1780 1782
19. Artlett C. M., Black C. M., Briggs D. C., Stevens C. O., Welsh K. I., Telomere reduction in scleroderma patients: a possible cause for chromosomal instability British Journal of Rheumatology 1996 35 8 732 737
20. Cawthon R. M., Telomere length measurement by a novel monochrome multiplex quantitative PCR method Nucleic Acids Research 2009 37 3, article e21
21. Hunting C. B., Noort W. A., Zwaginga J. J., Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization Vox Sanguinis 2005 88 1 1 9
22. Salvucci O., Maric D., Economopoulou M., Sakakibara S., Merlin S., Follenzi A., Tosato G., EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures Blood 2009 114 8 1707 1716
23. Guiducci S., Distler O., Distler J. H., Matucci-Cerinic M., Mechanisms of vascular damage in SScimplications for vascular treatment strategies Rheumatology 2008 47 v18 20
24. Armulik A., Abramsson A., Betsholtz C., Endothelial/pericyte interactions Circulation Research 2005 97 6 512 523 (Pubitemid 41361741)
25. von Tell D., Armulik A., Betsholtz C., Pericytes and vascular stability Experimental Cell Research 2006 312 5 623 629 (Pubitemid 43290338)
26. Allt G., Lawrenson J. G., Pericytes: cell biology and pathology Cells Tissues Organs 2001 169 1 1 11 (Pubitemid 32437039)
27. Collett G. D. M., Canfield A. E., Angiogenesis and pericytes in the initiation of ectopic calcification Circulation Research 2005 96 9 930 938 (Pubitemid 40712792)
28. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCormick M. K., Pericak-Vance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M., Marchuk D. A., Endoglin, a TGF- binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nature Genetics 1994 8 4 345 351
29. Goumans M.-J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P., Balancing the activation state of the endothelium via two distinct TGF- type I receptors The EMBO Journal 2002 21 7 1743 1753 (Pubitemid 34614630)
30. Jinnin M., Mechanisms of skin fibrosis in systemic sclerosis Journal of Dermatology 2010 37 1 11 25
31. Daz-Flores L., Gutirrez R., Madrid J. F., Varela H., Valladares F., Acosta E., Martn-Vasallo P., Daz-Flores L. Jr., Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche Histology and histopathology 2009 24 7 909 969
32. Cipriani P., Guiducci S., Miniati I., Cinelli M., Urbani S., Marrelli A., Dolo V., Pavan A., Saccardi R., Tyndall A., Giacomelli R., Matucci Cerinic M., Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis Arthritis Rheumatism 2007 56 6 1994 2004 (Pubitemid 47110398)
33. Del Papa N., Quirici N., Soligo D., Scavullo C., Cortiana M., Borsotti C., Maglione W., Comina D. P., Vitali C., Fraticelli P., Gabrielli A., Cortelezzi A., Lambertenghi-Deliliers G., Bone marrow endothelial progenitors are defective in systemic sclerosis Arthritis Rheumatism 2006 54 8 2605 2615 (Pubitemid 44205023)
34. Ruan J., Hajjar K., Rafii S., Leonard J. P., Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma Annals of Oncology 2009 20 3 413 424
35. Avouac J., Wipff J., Kahan A., Allanore Y., Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials Annals of the Rheumatic Diseases 2008 67 6 808 814 (Pubitemid 351829381)
36. Goumans M.-J., Lebrin F., Valdimarsdottir G., Controlling the angiogenic switch: a balance between two distinct TGF- receptor signaling pathways Trends in Cardiovascular Medicine 2003 13 7 301 307 (Pubitemid 37159396)
37. Del Papa N., Colombo G., Fracchiolla N., Moronetti L. M., Ingegnoli F., Maglione W., Comina D. P., Vitali C., Fantini F., Cortelezzi A., Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis Arthritis Rheumatism 2004 50 4 1296 1304 (Pubitemid 38480841)
38. Hunzelmann N., Brinckmann J., What are the new milestones in the pathogenesis of systemic sclerosis? Annals of the Rheumatic Diseases 2010 69 supplement 1 i52 i56
39. Rajantie I., Ilmonen M., Alminaite A., Ozerdem U., Alitalo K., Salven P., Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells Blood 2004 104 7 2084 2086 (Pubitemid 39297861)
40. Kuwana M., Okazaki Y., Kodama H., Satoh T., Kawakami Y., Ikeda Y., Endothelial differentiation potential of human monocyte-derived multipotential cells Stem Cells 2006 24 12 2733 2743 (Pubitemid 46053011)
41. Salvucci O., Yao L., Villalba S., Sajewicz A., Pittaluga S., Tosato G., Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1 Blood 2002 99 8 2703 2711 (Pubitemid 34525355)
42. Cipriani P., Milia A. F., Liakouli V., Pacini A., Manetti M., Marrelli A., Toscano A., Pingiotti E., Fulminis A., Guiducci S., Perricone R., Kahaleh B., Matucci-Cerinic M., Ibba-Manneschi L., Giacomelli R., Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications Arthritis Rheumatism 2006 54 9 3022 3033 (Pubitemid 44497784)
43. Campioni D., Lo Monaco A., Lanza F., Moretti S., Ferrari L., Fotinidi M., La Corte R., Cuneo A., Trotta F., CXCR4pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis Haematologica 2008 93 8 1233 1237
44. Kim S.-J., Kim J.-S., Papadopoulos J., Seung W. K., Maya M., Zhang F., He J., Fan D., Langley R., Fidler I. J., Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis American Journal of Pathology 2009 174 5 1972 1980
45. Andrews B. S., Friou G. J., Berman M. A., Sandborg C. I., Mirick G. R., Cesario T. C., Changes in circulating monocytes in patients with progressive systemic sclerosis Journal of Rheumatology 1987 14 5 930 935
46. York M. R., Nagai T., Mangini A. J., Lemaire R., van Seventer J. M., Lafyatis R., A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists Arthritis Rheumatism 2007 56 3 1010 1020 (Pubitemid 46399451)
47. Russo R., Medbury H., Guiffre A., Englert H., Manolios N., Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma Clinical Rheumatology 2007 26 7 1136 1141 (Pubitemid 46863961)
48. de Andrade J. A., Thannickal V. J., Innovative approaches to the therapy of fibrosis Current Opinion in Rheumatology 2009 21 6 649 655
49. van Laar J. M., Tyndall A., Cellular therapy of systemic sclerosis Current Rheumatology Reports 2008 10 3 189 194
50. Vannini N., Pfeffer U., Lorusso G., Noonan D. M., Albini A., Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model Current Pharmaceutical Design 2008 14 3 221 225 (Pubitemid 351516866)
51. Kuwana M., Okazaki Y., Kaburaki J., Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis Modern Rheumatology 2009 19 5 530 535
52. Mauro E., Rigolin G. M., Fraulini C., Sofritti O., Ciccone M., Angeli C. D., Castoldi G., Cuneo A., Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation European Journal of Haematology 2007 78 5 374 380 (Pubitemid 46558194)
53. Mikirova N. A., Jackson J. A., Hunninghake R., Kenyon J., Chan K. W.H., Swindlehurst C. A., Minev B., Patel A. N., Murphy M. P., Smith L., Alexandrescu D. T., Ichim T. E., Riordan N. H., Circulating endothelial progenitor cells: a new approach to anti-aging medicine? Journal of Translational Medicine 2009 7, article 106
54. Distler J. H.W., Distler O., Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies Annals of the Rheumatic Diseases 2010 69 supplement 1 i48 i51
55. Varga J., Pasche B., Antitransforming growth factor- therapy in fibrosis: recent progress and implications for systemic sclerosis Current Opinion in Rheumatology 2008 20 6 720 728
56. Lafyatis R., York M., Innate immunity and inflammation in systemic sclerosis Current Opinion in Rheumatology 2009 21 6 617 622
57. Postlethwaite A. E., Shigemitsu H., Kanangat S., Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis Current Opinion in Rheumatology 2004 16 6 733 738 (Pubitemid 39425547)